For the Inventor, By the Inventor

Enter inventor name

University Park, TX, United States of America

Eric N Olson

USPTO Granted Patents = 54 (Patent Applications = 19)

CIPO Patents = 4 (Patent Applications = 11)

EPO Patents = 7 (Patent Applications = 22)

Average Co-Inventor Count = 2.4

ph-index = 9

Forward Citations = 285(Granted Patents)

Forward Citations (Not Self Cited) = 255(Dec 10, 2025)

Inventors with similar research interests:

Location History:

University Park, TX (US) (2020 - 2021)
Dallas, TX (US) (1998 - 2022)

Company Filing History:

51 out of 5,445

University of Texas System

University of Colorado

Gilead Sciences, Inc.

Miragen Therapeutics, Inc.

5. 1 out of 240

The Administrators of the Tulane Educational Fund

6. 2 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

SERCA Pump

Myomaker-Induced Muscle Cell Fusion

NURR1 Activation

Micro-RNA Regulation

Cardiac Repair

Stem Cell Differentiation

Histone Deacetylase Inhibition

Cardiac Hypertrophy

Metabolic Disorders

Fibrosis Modulation

Neuromuscular Synapse Maintenance

Cardiomyocyte Survival

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12351609 - Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload (2025-07-08),

2. 11471509 - Compositions and methods relating to myomaker-induced muscle cell fusion (2022-10-18),

3. 11166949 - NURR1 activation in the treatment of metabolic disorders and as an exercise mimetic (2021-11-09),

4. 11111278 - Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload (2021-09-07),

5. 10687520 - Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44 (2020-06-23),

6. 10570183 - Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload (2020-02-25),

7. 10392618 - Micro-RNA family that modulates extracellular matrix genes and uses thereof (2019-08-27),

8. 10272137 - Compositions and methods relating to myomaker-induced muscle cell fusion (2019-04-30),

9. 9937156 - Modulation of MRTF-A activity in pathologic fibrosis and wound healing (2018-04-10),

10. 9719088 - Micro-RNA family that modulates fibrosis and uses thereof (2017-08-01),

11. 9719087 - Micro-RNA family that modulates fibrosis and uses thereof (2017-08-01),

12. 9719086 - Micro-RNA family that modulates fibrosis and uses thereof (2017-08-01),

13. 9598694 - Micro-RNAs involved in macular degeneration (2017-03-21),

14. 9523079 - Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes (2016-12-20),

15. 9428749 - Control of whole body energy homeostasis by microRNA regulation (2016-08-30),

Title: The Innovative Journey of Eric N. Olson

Introduction: Eric N. Olson, a distinguished inventor hailing from University Park, TX (US), is renowned for his groundbreaking contributions to the field of biotechnology and genetics.

Latest Patents: Eric N. Olson holds several patents in the realm of gene editing technologies, including a recent patent for a novel method of targeted gene therapy for muscular dystrophy.

Career Highlights: With a career spanning over three decades, Eric N. Olson has held key research positions at leading academic institutions such as the University of Texas Southwestern Medical Center. He has been instrumental in pioneering gene editing techniques that have revolutionized the treatment of genetic disorders.

Collaborations: Throughout his career, Eric N. Olson has collaborated with top researchers and biotech companies to further the development of gene therapy technologies. His partnerships have led to significant advancements in the field and have paved the way for innovative treatments for a range of genetic diseases.

Conclusion: Eric N. Olson's unwavering dedication to scientific innovation and his pioneering work in gene therapy have solidified his reputation as a trailblazer in the field of biotechnology. His contributions continue to inspire future generations of inventors and researchers in the quest for groundbreaking medical advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…